Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Harlan CRS, Bertin Pharma Enter Strategic Pact | Contract Pharma
Breaking News

Harlan CRS, Bertin Pharma Enter Strategic Pact

To offer comprehensive services for early drug development

Harlan Contract Research Services and Bertin Pharma, headquartered in Montigny-le-Bretonneux, France, have entered a strategic partnership to offer comprehensive services for early drug development. The companies will offer a wider range of drug discovery and translational medicine services, including expanded profiling and molecule testing, particularly in the context of regulatory studies. Harlan CRS will provide its drug discovery and translational medicine offerings using Bertin Pharma’s expertise in immunology and biomarkers.
 
“The new agreement benefits us both strategically and scientifically,” said Ciriaco Maraschiello, director of strategic initiatives and director of drug discovery and translational medicine at Harlan CRS. “Working together, we will provide the pharmaceutical industry the best team of scientists to increase the likelihood of success for new generation drugs.”
 
“For Bertin Pharma, this partnership will increase our international visibility and allow us to expand our services by integrating project management capabilities and expertise,” said Xavier Morge, managing director of Bertin Pharma.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters